4DMedical Limited (4DX) is a Company engaged in medical research technology and development of a non-invasive respiratory imaging solution using four-dimensional imaging.
Find out what a historical investment in 4Dmedical Call 0.75 AUD 4Dmedical 01Sep27 Opt would be worth today using our 4DXOB stock calculator.
Buying 4DXOB shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in 4Dmedical Call 0.75 AUD 4Dmedical 01Sep27 Opt in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in 4DXOB
What is the ticker symbol of 4Dmedical Call 0.75 AUD 4Dmedical 01Sep27 Opt?
The ticker symbol for 4Dmedical Call 0.75 AUD 4Dmedical 01Sep27 Opt is 4DXOB.
How much is one share of 4DXOB?
One share of 4DXOB is valued at $1.53 as of 20 November 2026.
What is the market capitalisation of 4Dmedical Call 0.75 AUD 4Dmedical 01Sep27 Opt 4DXOB?
As of 20 November 2026 4Dmedical Call 0.75 AUD 4Dmedical 01Sep27 Opt has a market cap of $1.36B.
What is the P/E ratio of 4DXOB?
The Price to Earnings ratio of 4DXOB is -4.12.
What is the Earnings Per Share of 4DXOB?
The Earnings Per Share of 4DXOB is -$0.38.
What is the 52-week high for 4Dmedical Call 0.75 AUD 4Dmedical 01Sep27 Opt stock?
The 4Dmedical Call 0.75 AUD 4Dmedical 01Sep27 Opt 52-week high stock price is $6.45.
What is the 52-week low for 4Dmedical Call 0.75 AUD 4Dmedical 01Sep27 Opt stock?
The 4Dmedical Call 0.75 AUD 4Dmedical 01Sep27 Opt 52-week low stock price is $1.00.
Can I buy 4DXOB shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy 4DXOB shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.